Mesenchymal Stromal Cells for the Treatment of Interstitial Lung Disease in Children: A Look from Pediatric and Pediatric Surgeon Viewpoints

Mesenchymal stromal cells (MSCs) have been proposed as a potential therapy to treat congenital and acquired lung diseases. Due to their tissue-regenerative, anti-fibrotic, and immunomodulatory properties, MSCs combined with other therapy or alone could be considered as a new approach for repair and...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelizzo, Gloria, Silvestro, Serena, Avanzini, Maria Antonietta, Zuccotti, Gianvincenzo, Mazzon, Emanuela, Calcaterra, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699409/
https://www.ncbi.nlm.nih.gov/pubmed/34943779
http://dx.doi.org/10.3390/cells10123270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699409/
https://www.ncbi.nlm.nih.gov/pubmed/34943779
http://dx.doi.org/10.3390/cells10123270

Ejemplares similares